Ozanimod as a novel oral small molecule therapy for the treatment of Crohn's disease: The YELLOWSTONE clinical trial program
奥扎尼莫德作为一种新型口服小分子疗法用于治疗克罗恩病：YELLOWSTONE临床试验项目
期刊:Contemporary Clinical Trials
影响因子:1.9
doi:10.1016/j.cct.2022.106958
Feagan, Brian G; Schreiber, Stefan; Afzali, Anita; Rieder, Florian; Hyams, Jeffrey; Kollengode, Kanthi; Pearlman, Jared; Son, Vladimir; Marta, Cecilia; Wolf, Douglas C; D'Haens, Geert G
